These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11295623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED.
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [Abstract] [Full Text] [Related]

  • 4. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
    Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM.
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
    [Abstract] [Full Text] [Related]

  • 5. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.
    Prostate; 2015 Aug 01; 75(11):1177-86. PubMed ID: 25893930
    [Abstract] [Full Text] [Related]

  • 6. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK, Saxena S, Singh UP, Goyal NK, Arora RP.
    Urol Oncol; 2005 Aug 01; 23(6):383-5. PubMed ID: 16301113
    [Abstract] [Full Text] [Related]

  • 7. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
    Stratton MS, Reid ME, Schwartzberg G, Minter FE, Monroe BK, Alberts DS, Marshall JR, Ahmann FR.
    Anticancer Drugs; 2003 Sep 01; 14(8):595-600. PubMed ID: 14501381
    [Abstract] [Full Text] [Related]

  • 8. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T, Oyen R, Van Poppel H.
    Prostate Cancer Prostatic Dis; 2003 Sep 01; 6(4):305-10. PubMed ID: 14663472
    [Abstract] [Full Text] [Related]

  • 9. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
    Clark LC, Dalkin B, Krongrad A, Combs GF, Turnbull BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J.
    Br J Urol; 1998 May 01; 81(5):730-4. PubMed ID: 9634050
    [Abstract] [Full Text] [Related]

  • 10. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA.
    J Urol; 2007 Jul 01; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [Abstract] [Full Text] [Related]

  • 11. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP.
    Cancer Epidemiol Biomarkers Prev; 2001 Aug 01; 10(8):861-8. PubMed ID: 11489752
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR.
    JAMA; 1996 Dec 25; 276(24):1957-63. PubMed ID: 8971064
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T.
    Oncotarget; 2017 May 30; 8(22):36674-36684. PubMed ID: 28415774
    [Abstract] [Full Text] [Related]

  • 18. SELECT: the selenium and vitamin E cancer prevention trial.
    Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.
    Urol Oncol; 2003 May 30; 21(1):59-65. PubMed ID: 12684129
    [Abstract] [Full Text] [Related]

  • 19. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG.
    J Cell Biochem Suppl; 1994 May 30; 19():191-6. PubMed ID: 7823591
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.
    J Clin Oncol; 2013 Feb 10; 31(5):523-9. PubMed ID: 23295793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.